Lunt H - Search Results

1

Postprandial capillary-venous glucose gradient in Type 1 diabetes: magnitude and clinical associations in a real world setting.

Lee I, Lunt H, Chan H, Heenan H, Berkeley J, Frampton CM. Lee I, et al. Among authors: lunt h. Diabet Med. 2016 Jul;33(7):998-1003. doi: 10.1111/dme.13025. Epub 2015 Dec 24. Diabet Med. 2016. PMID: 26536491 Free PMC article.

2

Use of insulin for 50 years or more in North Canterbury, New Zealand.

Lunt H, Brown LJ, Lake WP, Hegan KL. Lunt H, et al. Diabet Med. 1993 Mar;10(2):184-6. doi: 10.1111/j.1464-5491.1993.tb00040.x. Diabet Med. 1993. PMID: 8458199 Review.

3

Self-reported changes in capillary glucose and insulin requirements during the menstrual cycle.

Lunt H, Brown LJ. Lunt H, et al. Diabet Med. 1996 Jun;13(6):525-30. doi: 10.1002/(SICI)1096-9136(199606)13:6<525::AID-DIA123>3.0.CO;2-D. Diabet Med. 1996. PMID: 8799655

4

Women and diabetes.

Lunt H. Lunt H. Diabet Med. 1996 Dec;13(12):1009-16. doi: 10.1002/(SICI)1096-9136(199612)13:12<1009::AID-DIA281>3.0.CO;2-U. Diabet Med. 1996. PMID: 8973881 Review.

5

Cerebrovascular disease as a general medicine discharge diagnosis: assessment of diagnostic agreement on case note review.

Lunt H, Beard ME, Wilson MA, Kendall D, Frampton CM. Lunt H, et al. Aust N Z J Med. 1999 Jun;29(3):319-23. doi: 10.1111/j.1445-5994.1999.tb00714.x. Aust N Z J Med. 1999. PMID: 10868494

6

Prospective audit of conversion from regular to lispro insulin during routine clinical care.

Lunt H, Kendall D, Moore MP, Scott RS, Cole D, Frampton CM, Cullens M. Lunt H, et al. Intern Med J. 2004 Jun;34(6):320-3. doi: 10.1111/j.1444-0903.2004.00593.x. Intern Med J. 2004. PMID: 15228393

7

Prevalence of Type 1 diabetes in New Zealanders aged 0-24 years.

Wu D, Kendall D, Lunt H, Willis J, Darlow B, Frampton C. Wu D, et al. Among authors: lunt h. N Z Med J. 2005 Jul 15;118(1218):U1557. N Z Med J. 2005. PMID: 16027748

8

Diabetes epidemiology in New Zealand--does the whole picture differ from the sum of its parts?

Berkeley J, Lunt H. Berkeley J, et al. Among authors: lunt h. N Z Med J. 2006 Jun 2;119(1235):U2003. N Z Med J. 2006. PMID: 16751826 No abstract available.

9

Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use.

Berkeley J, Lunt H, Frampton C. Berkeley J, et al. Among authors: lunt h. Diabet Med. 2007 Dec;24(12):1496-7. doi: 10.1111/j.1464-5491.2007.02264.x. Epub 2007 Nov 1. Diabet Med. 2007. PMID: 17976206 No abstract available.

10

Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.

Moses RG, Bartley P, Lunt H, O'Brien RC, Donnelly T, Gall MA, Vesterager A, Wollmer P, Roberts A. Moses RG, et al. Among authors: lunt h. Diabet Med. 2009 Mar;26(3):260-7. doi: 10.1111/j.1464-5491.2008.02654.x. Diabet Med. 2009. PMID: 19317821 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters